EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico Screening and Anticancer-Apoptotic Evaluation of Newly Synthesized Thienopyrimidine/Sulfonamide Hybrids

Elshaymaa I Elmongy iD, Faizah A Binjubair, Ohoud Y Alshehri, Kholoud A Baeshen, Zaha A Almukhalfi, Hanan A Henidi iD

International Journal of Molecular Sciences · 29.06.2023 · 24 (13) · 10827

DOI: 10.3390/ijms241310827 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.06.2023. Verfasst von Elshaymaa I Elmongy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Helwan University, Ain Helwan, Cairo P.O. Box 11795, Egypt. Hauptthemen laut MEDLINE: Antineoplastic Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This work describes the design and synthesis of new hybrids of thienopyrimidine and sulfonamides. The binding affinity of the prepared compounds to FGFR-1 enzyme and caspase-3 was investigated via molecular docking. The cytotoxic effect was estimated for the synthesized compounds against human breast cancer cell lines (MCF-7 and MDA-MB231) using Doxorubicin as a reference. All the tested compounds exhibited moderate to excellent anticancer efficacy against both tested cell lines, among which 3b and 4bi were the best. All the synthesized compounds exhibited distinguishing selectivity index values greater than Doxorubicin. The influence of the new hybrids under inquiry was further examined on both FGFR-1 and Caspase-3. The results revealed that compound 3b showed observed concordance between anti-proliferative activity and Caspase-3 activity. In respect to the compounds’ effect on the apoptosis, compound 3b significantly increased the population of late apoptotic cells and necrotic cells. In silico pharmacokinetic investigation revealed that compound 3b showed the best intestinal absorption, BBB permeability, and, along with 4bi and 4bii, the best CNS penetrability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsHumansCaspase 3Structure-Activity RelationshipMolecular Docking SimulationCell Line, TumorCell ProliferationDoxorubicinSulfanilamideApoptosisDrug Screening Assays, AntitumorMolecular StructurePyrimidines

Stichwörter der Autor:innen

anticancerapoptosissulfonamidesthienopyrimidines

Substanzen

Caspase 3Antineoplastic AgentsDoxorubicinSulfanilamidethienopyrimidinePyrimidines

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Helwan University, Ain Helwan, Cairo P.O. Box 11795, Egypt.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
  • Department of Biochemistry, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11564, Saudi Arabia.
  • Research Department, Health Sciences Research Center, Princess Nourah Bint Abdulrahman University, Riyadh 84428, Saudi Arabia.

ORCID-Profile: Elshaymaa I Elmongy, Hanan A Henidi

Zitieren

APA

Elmongy, E. I., Binjubair, F. A., Alshehri, O. Y., Baeshen, K. A., Almukhalfi, Z. A., & Henidi, H. A. (2023). In Silico Screening and Anticancer-Apoptotic Evaluation of Newly Synthesized Thienopyrimidine/Sulfonamide Hybrids. International Journal of Molecular Sciences, 24(13), 10827. https://doi.org/10.3390/ijms241310827

Vancouver

Elmongy EI, Binjubair FA, Alshehri OY, Baeshen KA, Almukhalfi ZA, Henidi HA. In Silico Screening and Anticancer-Apoptotic Evaluation of Newly Synthesized Thienopyrimidine/Sulfonamide Hybrids. International Journal of Molecular Sciences. 2023;24(13):10827. doi:10.3390/ijms241310827

BibTeX
@article{Elmongy2023,
  author = {Elmongy, Elshaymaa I and Binjubair, Faizah A and Alshehri, Ohoud Y and Baeshen, Kholoud A and Almukhalfi, Zaha A and Henidi, Hanan A},
  title = {In Silico Screening and Anticancer-Apoptotic Evaluation of Newly Synthesized Thienopyrimidine/Sulfonamide Hybrids},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {13},
  pages = {10827},
  doi = {10.3390/ijms241310827}
}
Kostenlos starten →